3649 results for «414»
3649 results
Advancing transcatheter solutions for tricuspid valve disease
01 Feb 2025 – From PCR Imaging Valves Madrid 2025
This session delves into the latest advancements in transcatheter tricuspid valve interventions, covering procedural considerations, patient selection, and imaging techniques. Explore case studies, strategies for tricuspid transcatheter edge-to-edge repair, and key criteria for valve replacement. Learn about managing failed T-TEER cases and the role of transcatheter...
Optimizing diagnosis and treatment in multivalvular heart disease
01 Feb 2025 – From PCR Imaging Valves Madrid 2025
This session explores the diagnostic challenges and treatment strategies for mixed and multiple valvular heart diseases. Through case scenarios, including aortic stenosis, regurgitation, and combined atrioventricular valve regurgitation, learn how to use imaging modalities to assess severity and determine optimal treatment timing.
Mastering mitral valve disease: diagnosis, management, and intervention
31 Jan 2025 – From PCR Imaging Valves Madrid 2025
Dive into this comprehensive session on mitral valve disease, covering key aspects of diagnosis, classification, assessment, management, and patient selection for transcatheter intervention. Gain in-depth knowledge through real-world case studies and multidisciplinary team discussions, equipping you with essential skills to optimize patient care.
Navigating complexities in multivalvular heart disease: risk stratification, intervention timing, and advanced imaging
01 Feb 2025 – From PCR Imaging Valves Madrid 2025
This session explores the challenges of managing mixed and multiple valvular heart diseases, focusing on risk stratification, treatment decisions, and transcatheter intervention timing. Experts discuss assessing and treating aortic and mitral paravalvular leaks, as well as managing mitral annular calcification, using case studies to guide optimal...
Innvolution Healthcare reports one-year findings from the ALCHEMY study evaluating Eternia in 1000 patients at EuroPCR 2026
27 May 2026
Four-Year Outcomes from the EVOLUT Low Risk Trial
26 Oct 2023
Dejan Milasinovic provides his take on the EVOLUT Low Risk trial, presented by Michael I. Reardon at TCT Congress 2023. 4-year results reveal a continuing trend towards lower combined rates of all-cause mortality and disabling stroke with TAVI compared with surgical aortic valve replacement (SAVR)
Author
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.
Author
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial
01 Apr 2025
Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.
Author
